Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of Octafibrin for on-demand treatment in paediatric congenital fibrinogen deficiency
2014-005115-16Phase 3
- Sponsor
- Octapharma
- Start
- Apr 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of Fibrinogen human in fibrinogen deficiency, sponsored by Octapharma.
02
Drugs
Fibrinogen human
03
Conditions
fibrinogen deficiency
Beyond the preview
Go deeper on 2014-005115-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-005115-16.